Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST001165)

Reversed phase NEGATIVE ION MODE (Analysis AN001927)

Metabolite	Structure	F1	F2	F3	F4
FA (20:0) (arachidicacid)	ME277542	0.61	2.36	0.50	0.53
FA (22:0) (behenicacid)	ME277549	0.43	2.74	0.38	0.45
PC (34:1)	ME277560	1.40	0.88	0.71	1.01
PC (36:4) B	ME277565	0.81	1.06	0.93	1.20
GlcCer(d14:1(4E)/20:0(2OH))	ME277552	0.80	1.06	0.88	1.26
PC (34:3)	ME277562	0.80	1.07	0.90	1.22
PC (36:5) A	ME277566	0.81	1.08	0.89	1.23
PC (38:6)	ME277570	0.76	1.02	0.87	1.35
PC (36:4) A	ME277564	0.75	1.09	0.89	1.27
PC (34:4)	ME277563	0.73	1.08	0.88	1.31
PC (36:5) B	ME277567	0.76	1.06	0.88	1.30
PC (38:5) A	ME277568	0.82	0.98	0.97	1.24
PC (p-38:5) or PC (o-38:6)	ME277578	0.83	1.01	0.95	1.21
PE (p-38:2) or PE (o-38:3)	ME277586	0.82	1.00	0.94	1.23
LPC (16:0)	ME277553	0.85	0.96	0.94	1.25
LPE (16:0)	ME277555	0.86	0.92	0.94	1.28
PE (p-36:4) or PE (o-36:5)	ME277584	0.94	1.07	0.88	1.10
PE (p-38:5) or PE (o-38:6)	ME277588	0.91	1.09	0.86	1.13
PC (p-36:3) or PC (o-36:4)	ME277576	0.93	1.00	0.95	1.13
PE (p-36:1) or PE (o-36:2)	ME277582	0.91	0.97	0.96	1.16
LPC (20:3)	ME277554	0.90	0.99	0.97	1.15
PC (p-38:4) or PC (o-38:5) A	ME277577	0.90	1.00	0.97	1.13
PC (32:0)	ME277557	0.92	0.96	0.93	1.19
PC (p-34:1) or PC (o-34:2) B	ME277575	0.89	1.00	0.94	1.17
PE (p-40:6) or PE (o-40:7)	ME277591	0.89	0.99	0.93	1.19
PC (p-34:0) or PC (o-34:1)	ME277574	0.85	1.04	0.94	1.17
PE (p-36:2) or PE (o-36:3)	ME277583	0.84	1.06	0.94	1.17
PC (32:2)	ME277559	0.84	1.04	0.97	1.15
PE (36:4)	ME277579	0.86	1.05	0.95	1.14
PE (38:4) B	ME277580	0.91	1.05	0.94	1.10
PC (34:2)	ME277561	0.90	1.04	0.91	1.15
PC (38:5) B	ME277569	0.89	1.03	0.95	1.14
PC (32:1)	ME277558	0.87	1.02	0.87	1.24
PC (40:7)	ME277571	0.88	1.01	0.88	1.23
PE (p-36:5) or PE (o-36:6)	ME277585	0.94	1.04	0.85	1.17
PE (p-38:6) or PE (o-38:7)	ME277589	0.94	0.99	0.87	1.20
PE (38:6)	ME277581	1.05	0.92	0.86	1.17
FA (18:1) (oleicacid)	ME277539	1.09	1.03	0.83	1.05
PE (p-40:5) or PE (o-40:6)	ME277590	1.15	0.92	0.87	1.06
FA (20:1) (eicosenoicacid)	ME277543	1.04	1.08	1.05	0.83
FA (22:6) (docosahexaenoicacid)	ME277551	1.00	1.18	1.05	0.76
FA (18:0) (stearicacid)	ME277538	1.16	1.08	0.86	0.90
FA (17:0) (margaricacid)	ME277536	1.06	1.07	0.93	0.94
PC (p-32:0) or PC (o-32:1)	ME277573	1.13	1.02	0.91	0.94
PC (o-32:0)	ME277572	1.06	0.87	1.03	1.04
1_SM (d18:1/17:0) iSTD	ME277532	1.05	0.99	1.00	0.96
FA (20:4) (arachidonicacid)	ME277547	1.05	1.00	1.01	0.93
1_CUDA iSTD	ME277524	0.99	1.03	0.99	0.99
1_PC (12:0/13:0) iSTD	ME277529	1.00	1.01	1.00	0.99
1_FA (16:0)-d3 iSTD	ME277525	1.02	1.03	0.97	0.99
1_PE (17:0/17:0) iSTD	ME277530	1.04	1.00	0.97	0.99
1_PG (17:0/17:0) iSTD	ME277531	1.03	1.00	0.97	0.99
1_Ceramide (d18:1/17:0) iSTD	ME277523	1.02	1.00	0.99	0.98
1_LPC (17:0) iSTD	ME277526	1.03	1.00	1.00	0.98
1_LPE (17:1) iSTD	ME277527	1.02	1.01	0.99	0.99
1_MAG (17:0/0:0/0:0) iSTD	ME277528	1.02	1.01	0.98	0.98
FA (18:2) (linoleicacid)	ME277540	0.98	1.00	0.94	1.08
Ceramide (d34:1)	ME277533	1.01	0.94	0.99	1.06
LPE (20:4)	ME277556	0.99	0.98	0.99	1.04
FA (15:0) (pentadecylicacid)	ME277534	0.99	1.13	0.91	0.97
FA (20:5) (eicosapentaenoicacid)	ME277548	0.92	1.08	0.97	1.03
FA (20:2) (eicosadienoicacid)	ME277544	0.97	1.03	1.06	0.94
FA (20:3) (eicosatrienoicacid)	ME277545	0.97	1.07	1.00	0.95
FA (22:2) (docosadienoicacid)	ME277550	0.96	1.07	1.09	0.88
FA (16:1) (palmitoleicacid)	ME277535	0.96	1.12	1.02	0.90
FA (20:3) (homo-gamma-linolenicacid)	ME277546	0.93	1.13	1.03	0.91
PE (p-38:3) or PE (o-38:4)	ME277587	0.94	0.96	1.06	1.04
FA (17:1) (heptadecenoicacid)	ME277537	0.89	1.01	1.14	0.96
FA (18:3) (linolenicacid)	ME277541	0.90	1.04	1.09	0.98

Factors:

F1	ph treatment:High \| DO treatment:High
F2	ph treatment:High \| DO treatment:Low
F3	ph treatment:Low \| DO treatment:High
F4	ph treatment:Low \| DO treatment:Low

Data matrix